Russell Investments Group’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $18.5K | Sell |
16,562
-62,815
| -79% | -$70.3K | ﹤0.01% | 3207 |
|
|
2025
Q1 | $62.7K | Sell |
79,377
-10,446
| -12% | -$8.25K | ﹤0.01% | 2853 |
|
|
2024
Q4 | $148K | Buy |
89,823
+26,953
| +43% | +$44.5K | ﹤0.01% | 2606 |
|
|
2024
Q3 | $220K | Sell |
62,870
-39,063
| -38% | -$137K | ﹤0.01% | 2491 |
|
|
2024
Q2 | $334K | Sell |
101,933
-8,315
| -8% | -$27.3K | ﹤0.01% | 2341 |
|
|
2024
Q1 | $809K | Sell |
110,248
-123,500
| -53% | -$906K | ﹤0.01% | 2049 |
|
|
2023
Q4 | $874K | Buy |
233,748
+59,267
| +34% | +$222K | ﹤0.01% | 2021 |
|
|
2023
Q3 | $370K | Sell |
174,481
-12,995
| -7% | -$27.5K | ﹤0.01% | 2326 |
|
|
2023
Q2 | $892K | Buy |
187,476
+15,386
| +9% | +$73.2K | ﹤0.01% | 1991 |
|
|
2023
Q1 | $981K | Buy |
172,090
+171,561
| +32,431% | +$978K | ﹤0.01% | 1972 |
|
|
2022
Q4 | $5.34K | Hold |
529
| – | – | ﹤0.01% | 2862 |
|
|
2022
Q3 | $11K | Hold |
529
| – | – | ﹤0.01% | 2854 |
|
|
2022
Q2 | $13K | Hold |
529
| – | – | ﹤0.01% | 2830 |
|
|
2022
Q1 | $20K | Hold |
529
| – | – | ﹤0.01% | 2681 |
|
|
2021
Q4 | $30K | Hold |
529
| – | – | ﹤0.01% | 2928 |
|
|
2021
Q3 | $31K | Sell |
529
-4,395
| -89% | -$258K | ﹤0.01% | 2975 |
|
|
2021
Q2 | $427K | Sell |
4,924
-33,812
| -87% | -$2.93M | ﹤0.01% | 2662 |
|
|
2021
Q1 | $3.19M | Sell |
38,736
-20,912
| -35% | -$1.72M | 0.01% | 1602 |
|
|
2020
Q4 | $5.43M | Sell |
59,648
-8,603
| -13% | -$783K | 0.01% | 1200 |
|
|
2020
Q3 | $2.73M | Hold |
68,251
| – | – | 0.01% | 1493 |
|
|
2020
Q2 | $2.34M | Sell |
68,251
-30,827
| -31% | -$1.06M | 0.01% | 1540 |
|
|
2020
Q1 | $2.2M | Sell |
99,078
-58,280
| -37% | -$1.29M | 0.01% | 1419 |
|
|
2019
Q4 | $3.08M | Buy |
157,358
+66,681
| +74% | +$1.3M | 0.01% | 1487 |
|
|
2019
Q3 | $1.41M | Buy |
+90,677
| New | +$1.41M | ﹤0.01% | 1849 |
|
|
2017
Q4 | – | Sell |
-59,168
| Closed | -$234K | – | 2968 |
|
|
2017
Q3 | $234K | Buy |
+59,168
| New | +$234K | ﹤0.01% | 2640 |
|